Each mL of ReBalance Antiprotozoal Oral Suspension contains 250 mg of sulfadiazine ( as the sodium salt) and 12.5 mg pyrimethamine and is available in 946.4 mL (1 Quart) multiple dose child resistant, screw-capped bottles.
For a Material Safety Data Sheet (MSDS) or to report Adverse Reactions, call Pegasus Laboratories, Inc. at 1-800-874-9764.
US patent No. 5,747,476; 6,255,308 and 6,448,252
Trademarks are property of Pegasus Laboratories, Inc.
Pegasus Laboratories, Inc.
An Employee Owned Company
Pensacola, FL 32514, USA
Antiprotozoal Oral Suspension
(Sulfadiazine and Pyrimethamine)
Caution: Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Shake Well before Each Use
For oral Use in Horses Only
Keep Out of Reach of Children
Treatment for Equine Protozoal Myeloencephalitis (EPM) In Horses
NADA 141-240, Approved by FDA
PRN Pharmacal, Pegasus Laboratories, Inc.
NET CONTENTS: 946.4 mL (One Quart)
| REBALANCE ANTIPROTOZOAL |
sulfadiazine and pyrimethamine suspension
|Labeler — Pegasus Laboratories, Inc (108454760)|
|Registrant — Pegasus Laboratories, Inc (108454760)|
|Pegasus Laboratories, Inc||108454760||manufacture, analysis, label|
Revised: 11/2019 Pegasus Laboratories, Inc
VetLabel.com provides trustworthy package insert and label information about marketed drugs as submitted by manufacturers to the U.S. Food and Drug Administration. Package information is not reviewed or updated separately by VetLabel.com. Every individual animal healthcare product label entry contains a unique identifier which can be used to secure further details directly from the U.S. National Institutes of Health and/or the FDA.